NOVALUNG

We offer extracorporeal membrane oxygenation (ECMO) treatments for patients suffering from cardiac and/or pulmonary failure. Based on a holistic understanding of human physiology, we develop extracorporeal life support (ECLS) technologies that can be vital for the survival of critically ill patients.[1-3]... We provide solutions that combine both cardiac and pulmonary support on one single technological platform, the Xenios console. It supports gas exchange in the lungs and the cardiovascular system. ECMO thus provides physicians with crucial time for diagnosis and therapy.[1]... We offer jobs with excellent prospects in the medical device industry. Discover your opportunities now!

Also known as: Novalung GmbH

Registration numbers: HRB 743620 (W)

VAT numbers: DE 286481056

Primary location: Heilbronn Germany